Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP468870.RA_ai9L6QGF8fo6L9rHEPrZufj6DfQBxXFitXD21GV3fo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP468870.RA_ai9L6QGF8fo6L9rHEPrZufj6DfQBxXFitXD21GV3fo130_assertion type Assertion NP468870.RA_ai9L6QGF8fo6L9rHEPrZufj6DfQBxXFitXD21GV3fo130_head.
- NP468870.RA_ai9L6QGF8fo6L9rHEPrZufj6DfQBxXFitXD21GV3fo130_assertion description "[KRAS and BRAF mutations occur in colorectal cancers (CRCs) and are considered mutually exclusive methods of activating the RAS/RAF/MEK/ERK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468870.RA_ai9L6QGF8fo6L9rHEPrZufj6DfQBxXFitXD21GV3fo130_provenance.
- NP468870.RA_ai9L6QGF8fo6L9rHEPrZufj6DfQBxXFitXD21GV3fo130_assertion evidence source_evidence_literature NP468870.RA_ai9L6QGF8fo6L9rHEPrZufj6DfQBxXFitXD21GV3fo130_provenance.
- NP468870.RA_ai9L6QGF8fo6L9rHEPrZufj6DfQBxXFitXD21GV3fo130_assertion SIO_000772 19474002 NP468870.RA_ai9L6QGF8fo6L9rHEPrZufj6DfQBxXFitXD21GV3fo130_provenance.
- NP468870.RA_ai9L6QGF8fo6L9rHEPrZufj6DfQBxXFitXD21GV3fo130_assertion wasDerivedFrom befree-20140225 NP468870.RA_ai9L6QGF8fo6L9rHEPrZufj6DfQBxXFitXD21GV3fo130_provenance.
- NP468870.RA_ai9L6QGF8fo6L9rHEPrZufj6DfQBxXFitXD21GV3fo130_assertion wasGeneratedBy ECO_0000203 NP468870.RA_ai9L6QGF8fo6L9rHEPrZufj6DfQBxXFitXD21GV3fo130_provenance.